These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24186700)

  • 81. Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis.
    Levy ML; Hardwell A; McKnight E; Holmes J
    Prim Care Respir J; 2013 Dec; 22(4):406-11. PubMed ID: 24042172
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Adachi M; Goldfrad C; Jacques L; Nishimura Y
    Respir Med; 2016 Nov; 120():78-86. PubMed ID: 27817819
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effectiveness of combination therapies in asthma: an observational study.
    Suissa S; Dell'Aniello S; Ernst P
    Pulm Pharmacol Ther; 2009 Jun; 22(3):194-8. PubMed ID: 19063985
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
    Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
    J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Economic evaluations.
    Anthonisen NR
    Can Respir J; 2007; 14(5):264-6. PubMed ID: 17874484
    [No Abstract]   [Full Text] [Related]  

  • 86. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ; Currie GP; Lipworth BJ
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
    Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA; Riedel AA; Carranza Rosenzweig JR
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments.
    Wang SW; Liu X; Wiener DJ; Sennett C; Bowers BW; Legorreta AP
    Am J Manag Care; 2001 Sep; 7(9):913-22. PubMed ID: 11570024
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Sao Paulo Med J; 2010; 128(5):310-1. PubMed ID: 21181075
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E; FitzGerald JM
    Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
    Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients.
    Dal NR; Eandi M; Pradelli L; Iannazzo S
    Int J Chron Obstruct Pulmon Dis; 2007; 2(2):169-76. PubMed ID: 18044689
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients.
    Price D; Thomas V; von Ziegenweidt J; Gould S; Hutton C; King C
    J Asthma Allergy; 2014; 7():31-51. PubMed ID: 24748807
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform(®)) for the treatment of asthma.
    Tan RA; Corren J
    Drug Des Devel Ther; 2014; 8():1555-61. PubMed ID: 25328383
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam.
    Aggarwal B; Jones PW; Yunus F; Lan LTT; Boonsawat W; Ismaila A; Ascioglu S
    J Asthma; 2022 Jun; 59(6):1213-1220. PubMed ID: 33764239
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A clinical pharmacology study of fixed vs. free combination of inhaled beclometasone dipropionate and formoterol fumarate dry powder inhalers in asthmatic adolescents.
    Chawes BL; Govoni M; Piccinno A; Kreiner-Møller E; Vissing NH; Mortensen L; Nilsson E; Bisgaard A; Deleuran M; Skytt N; Samandari N; Acerbi D; Bisgaard H
    Br J Clin Pharmacol; 2014 Nov; 78(5):1169-71. PubMed ID: 24830339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.